CCL22 and neoplasm: When the chemokine CCL22, produced by macrophages, as well as tumor cells of ovarian cancer, is secreted, regulatory T cells are further clustered to suppress T cell-mediated immune response against tumor cells, thus creating an environment that promotes cancer growth [41].